TCTR20210929007尚未招募3 期
Efficacy of Regional Citrate Anticoagulation versus SalineFlushingduring Intermittent Hemodialysis on blood circuit clotting prevention;A Randomized Clinical Trial (The Citra-Saline-IHD)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Acute setting ; AKI,ESRD Age > 18 yrs Informed consent Undergoing central venous catheters or AVF/AVG, by prescription HD: Low flux dialyzer BFR 200 ml/min Dialyzate Ca 1.75 mEq/L Duration 4 hr
排除标准
- •1.Patients were treated with antiplatelet,oral anticoagulant therapy or other drugs known to affect coagulation within 7 days 2. Acute liver failure 3. DIC 4. Contraindication to systemic anticoagulation: Abnormal plasma total calcium < 7.0 mg/dL Abnormal plasma total magnesium <1.8 mg/dL Abnormal plasma total sodium >145 mg/dL metabolic alkalosis; serum bicarb > 28 mEq/L Known allergy to citrate Documented arrhythmia
研究者
相似试验
已完成
不适用
Regional citrate anti-coagulation for continuous renal replacement therapy in patients with acute kidney injuryAcute kidney injuryACTRN12611000099921Department of intensive care, Pamela Youde Nethersole Eastern Hospital10
招募中
3 期
Regional Citrate Anticoagulation for acute intermittent hemodialysis versus saline flushing for safety, efficacy and effect on prolong life of blood circuit of hemodialysis machine; Randomized controlled trialHypocalcemia,lead to numbness,carpopedal spasm,seizure and arrhythmiaMetabolic alkalosisTCTR20200630004Government300
进行中（未招募）
1 期
Investigating different anticoagulants for renal replacement therapyEUCTR2014-004854-33-DEniversity Hospital Muenster1,450
已完成
4 期
Investigating Different Anticoagulants for Renal Replacement TherapyAcute Kidney InjuryNCT02669589University Hospital Muenster638
尚未招募
不适用
Citrate for blood anticoagulation in continuous dialysis circuitCTRI/2022/08/045125Anant Vikram Pachisia